logo
搜索
菜单

arrhythmia的搜索结果

当前1/2页
排序: 总浏览数
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation 10.3791/3671-v
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation 10.3791/3818-v
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart 10.3791/3275-v
Optical Mapping of Action Potentials and Calcium Transients in the Mouse Heart
Ambulatory ECG Recording in Mice 10.3791/1739-v 08:00 min
Ambulatory ECG Recording in Mice
Multiparametric Optical Mapping of the Langendorff-perfused Rabbit Heart 10.3791/3160-v
Multiparametric Optical Mapping of the Langendorff-perfused Rabbit Heart
Optical Mapping of Langendorff-perfused Rat Hearts 10.3791/1138-v 11:48 min
Optical Mapping of Langendorff-perfused Rat Hearts
Programmed Electrical Stimulation in Mice 10.3791/1730-v 07:29 min
Programmed Electrical Stimulation in Mice
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus 10.3791/2726-v 08:28 min
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation 10.3791/3103-v 09:17 min
High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels 10.3791/3850-v 05:31 min
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
February 2012: This Month in JoVE 10.3791/4258-v
February 2012: This Month in JoVE
9.1: Cardiovascular Drugs: Classification based on Therapeutic Indications 01:18 min
9.1: Cardiovascular Drugs: Classification based on Therapeutic Indications
14.14: Holter Monitor: 24-Hour Monitoring 01:23 min
14.14: Holter Monitor: 24-Hour Monitoring
10.3: Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers 01:22 min
10.3: Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
23.12: Disturbances in Heart Rhythm 01:29 min
23.12: Disturbances in Heart Rhythm
10.5: Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers 01:12 min
10.5: Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
30.7: Roles of Electrolytes: Sodium and Potassium 01:24 min
30.7: Roles of Electrolytes: Sodium and Potassium
10.2: Mechanism of Cardiac Arrhythmias 01:28 min
10.2: Mechanism of Cardiac Arrhythmias
24.14: Pulse 01:16 min
24.14: Pulse
10.4: Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers 01:24 min
10.4: Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
返回顶部